Financial statements Biodec
Balance sheet data of BIODEC
|
Year
|
2021
|
2022
|
2023
|
|---|---|---|---|
| Total assets | 128 795,72 | 293 359,21 | 280 658,58 |
| A. Fixed assets | 21 003,78 | 13 698,12 | 53 698,12 |
| B. Current assets | 107 791,94 | 279 661,09 | 226 960,46 |
| C. Share capital contributions (basic funds) | - | - | - |
| D. Own shares (stocks) | - | - | - |
| Total liabilities | 128 795,72 | 293 359,21 | 280 658,58 |
| A. Equity | 35 449,99 | 179 024,78 | 225 182,86 |
| B. Liabilities and provisions for liabilities | 93 345,73 | 114 334,43 | 55 475,72 |
| I. Long-term liabilities | - | - | - |
| II. Short-term liabilities | - | 114 334,43 | 55 475,72 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.